Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Puma Biotechnology (PBYI) over the last 8 years, with Q3 2025 value amounting to 0.29%.

  • Puma Biotechnology's Return on Capital Employed fell 300.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.25% for FY2024, which is 100.0% down from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Return on Capital Employed is 0.29%, which was down 300.0% from 0.4% recorded in Q2 2025.
  • Puma Biotechnology's 5-year Return on Capital Employed high stood at 0.4% for Q2 2025, and its period low was 0.19% during Q1 2022.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.18% (2023), whereas its average is 0.14%.
  • Per our database at Business Quant, Puma Biotechnology's Return on Capital Employed soared by 4900bps in 2021 and then crashed by -2300bps in 2022.
  • Over the past 5 years, Puma Biotechnology's Return on Capital Employed (Quarter) stood at 0.05% in 2021, then surged by 451bps to 0.18% in 2022, then surged by 55bps to 0.28% in 2023, then dropped by -8bps to 0.26% in 2024, then rose by 13bps to 0.29% in 2025.
  • Its last three reported values are 0.29% in Q3 2025, 0.4% for Q2 2025, and 0.32% during Q1 2025.